KRAS G12C/D/V mutations PROGRAM（AnHorn Medicines）
N/A
Report date: 2023/12/25 17:41:33
NME
Base Information
Drug NameKRAS G12C/D/V mutations PROGRAM（AnHorn Medicines）
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnHorn Medicines Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAnHorn Medicines Co Ltd
Inactive CompaniesN/A
Active Indications +[5]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A